Unknown

Dataset Information

0

Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis.


ABSTRACT: The ongoing Corona Virus Disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has emphasized the urgent need for antiviral therapeutics. The viral RNA-dependent-RNA-polymerase (RdRp) is a promising target with polymerase inhibitors successfully used for the treatment of several viral diseases. We demonstrate here that Favipiravir predominantly exerts an antiviral effect through lethal mutagenesis. The SARS-CoV RdRp complex is at least 10-fold more active than any other viral RdRp known. It possesses both unusually high nucleotide incorporation rates and high-error rates allowing facile insertion of Favipiravir into viral RNA, provoking C-to-U and G-to-A transitions in the already low cytosine content SARS-CoV-2 genome. The coronavirus RdRp complex represents an Achilles heel for SARS-CoV, supporting nucleoside analogues as promising candidates for the treatment of COVID-19.

SUBMITTER: Shannon A 

PROVIDER: S-EPMC7499305 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis.

Shannon Ashleigh A   Selisko Barbara B   Le Nhung-Thi-Tuyet NT   Huchting Johanna J   Touret Franck F   Piorkowski Géraldine G   Fattorini Véronique V   Ferron François F   Decroly Etienne E   Meier Chris C   Coutard Bruno B   Peersen Olve O   Canard Bruno B  

Nature communications 20200917 1


The ongoing Corona Virus Disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has emphasized the urgent need for antiviral therapeutics. The viral RNA-dependent-RNA-polymerase (RdRp) is a promising target with polymerase inhibitors successfully used for the treatment of several viral diseases. We demonstrate here that Favipiravir predominantly exerts an antiviral effect through lethal mutagenesis. The SARS-CoV RdRp complex is at least 10-fold  ...[more]

Similar Datasets

| S-EPMC5068784 | biostudies-literature
| S-EPMC6658772 | biostudies-literature
| S-EPMC5655064 | biostudies-literature
| S-EPMC3879444 | biostudies-literature
| S-EPMC2883602 | biostudies-literature
| S-EPMC6158410 | biostudies-literature
| S-EPMC7952560 | biostudies-literature
| S-EPMC2818889 | biostudies-other
| S-EPMC7828521 | biostudies-literature
| S-EPMC3307711 | biostudies-literature